Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
 

Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

on

  • 99 views

Market Research Reports, Inc. has announced the addition of “Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” research report to their offering. See more at- ...

Market Research Reports, Inc. has announced the addition of “Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” research report to their offering. See more at- http://mrr.cm/ZW2

Statistics

Views

Total Views
99
Views on SlideShare
97
Embed Views
2

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 2

http://www.slideee.com 2

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Presentation Transcript

  • www.MarketResearchReports.com Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  • www.MarketResearchReports.com Introduction to Report  Launch Date: July 1, 2014  Number of Pages: 2168  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 3,295 Price For Site License: USD 9,895 Price For Global User License: USD 16,495 Delivery Time: Within 24 Hours (During Working Days)
  • www.MarketResearchReports.com About the Report The Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter distribution deals. The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration.
  • www.MarketResearchReports.com Research Findings Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in distribution as well as a discussion on the merits of the type of deal. Chapter 3 provides an overview of the structure of distribution deals. The chapter includes numerous case studies to enable understanding of both pure distribution deals and multicomponent deals where distribution forms a part. Chapter 4 provides a review of the leading distribution deals since 2009. Deals are listed by headline value, signed by big pharma and big biotech, most active bigpharma and bigbiotech, and most active of all biopharma companies.
  • www.MarketResearchReports.com Research Findings Continues… Chapter 5 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of distribution deals available in the public domain. Chapter 6 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of distribution deals available in the public domain. Chapter 7 provides a comprehensive and detailed review of distribution deals organized by company A-Z, therapy, technology and industry type signed and announced since 2009 where a contract document is available.
  • www.MarketResearchReports.com Key Benefits: In-depth understanding of distribution deal trends since 2009 Analysis of the structure of distribution agreements with numerous real life case studies Comprehensive access to over 2,000 actual distribution deals entered into by the world’s biopharma companies Detailed access to actual distribution contracts enter into by the leading fifty bigpharma companies Insight into the terms included in a distribution agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies
  • www.MarketResearchReports.com Report Coverage 1. Executive Summary 2. Introduction 3. Trends in distribution dealmaking 4. Overview of distribution deal structure 5. Leading distribution deals 6. Big pharma distribution deals 7. Big biotech distribution deals 8. Distribution contracts directory For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  • www.MarketResearchReports.com Company Coverage (Partial List) 1. Abbott 2. Actavis 3. Actelion 4. Allergan 5. Amgen 6. Anika Therapeutics 7. Astellas 8. AstraZeneca 9. Baxter International 10.Bayer 11.Biocon 12.BioMarin Pharmaceuticals 13.Boehringer Ingelheim 14.Bristol-Myers Squibb For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  • www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center
  • www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/ZW2 About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India)